In addition, results of a previous study revealed that serum GKN1 levels may aid in distinguishing individuals with CRC from those with CRC, liver, lung, breast, pancreatic, ovarian or prostate cancers that exhibited area under the curve (AUC) values of >0.94 (80). This evidence concerns the gene GKN1 and prostate carcinoma.